Skip to Content
Translational Research Program (TRP)
Contact CIP
Show menu
Search this site
Last Updated: 10/10/18

Pancreatic SPOREs

Pancreatic cancer is the 4th leading cause of cancer death in the United States. Over 53,070 newly diagnosed cases and an estimated 41,780 deaths are expected in the United States in the year 2016. Presently, surgery, radiation and chemotherapies are treatment options that can extend survival and/or relieve symptoms in these patients, but seldom produce a cure. Patients with cancers of the pancreas have a particularly poor prognosis, as mortality from of this cancer is extremely high (5-year survival rate is <5%). Currently, the investigators from pancreatic cancer SPOREs are working closely with the researchers in GI Cancer SPOREs. Pancreatic SPOREs and GI SPOREs having projects in pancreatic cancer are developing screening protocols to collect biospecimens from early lesions, fluid from cysts, circulating tumor cells, or DNA from serum. These biospecimens could help in the development of new molecular or imaging biomarkers that could be used in the selection of pancreatic cancer patients for early surgical intervention.